Japan Lags Behind Emerging Nations In Conducting Joint Clinical Trials
This article was originally published in PharmAsia News
Executive Summary
Japan lags many other nations, including several emerging ones, in conducting joint international clinical trials of drugs, a contributing factor to Japan's longer drug-approval process.